Andrew S. Kraft

Overview

Best Publications

• Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.

  Andrew S. Kraft;Wayne B. Anderson

  1903
  Citations

• Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

  Robert G. Maki;David R. D'Adamo;Mary L. Keohan;Michael Saulle

  648
  Citations

• Conditional Expression of the Mitogen-activated Protein Kinase (MAPK) Phosphatase MKP-1 Preferentially Inhibits p38 MAPK and Stress-activated Protein Kinase in U937 Cells

  Christopher C. Franklin;Andrew S. Kraft

  647
  Citations

• Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells.

  A S Kraft;W B Anderson;H L Cooper;J J Sando

  563
  Citations

• The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.

  Weiqing Zhang;Deborah E. Geiman;Janiel M. Shields;Duyen T. Dang

  420
  Citations

• Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis

  Alexandre Nesterov;Xiaojun Lu;Michael Johnson;Gary J. Miller

  390
  Citations

• The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell Death

  Bin Yan;Marina Zemskova;Sheldon Holder;Vernon Chin

  357
  Citations

• Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60

  Andrew S. Kraft;Jeffrey B. Smith;Roger L. Berkow

  357
  Citations

• Bax-induced apoptotic cell death.

  John Pawlowski;Andrew S. Kraft

  312
  Citations

• The 2014 Surgeon General's report: “The Health Consequences of Smoking–50 Years of Progress”: A paradigm shift in cancer care

  Graham W. Warren;Anthony J. Alberg;Andrew S. Kraft;K. Michael Cummings

  309
  Citations

• The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells

  Joseph R. Biggs;Jeffery E. Kudlow;Andrew S. Kraft

  261
  Citations

• Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor

  Stuart J. Frank;Stuart J. Frank;Woelsung Yi;Yanming Zhao;Jeffrey F. Goldsmith

  254
  Citations

• The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.

  Thomas R. Johnson;Kimberley Stone;Malti Nikrad;Tammie Yeh

  249
  Citations

• The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim

  Malti Nikrad;Thomas Johnson;Thomas Johnson;Hamsa Puthalalath;Leigh Coultas

  249
  Citations

• The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.

  Michael Lilly;Jouko Sandholm;John J Cooper;Päivi J Koskinen

  239
  Citations

• Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis

  Christopher C. Franklin;Sampathkumar Srikanth;Andrew S. Kraft

  234
  Citations

• PIM kinase (and Akt) biology and signaling in tumors.

  Noel A. Warfel;Andrew S. Kraft

  223
  Citations

• Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

  Gary K. Schwartz;William D. Tap;Li Xuan Qin;Michael B. Livingston

  217
  Citations

• The Amino-terminal Portion of the JAK2 Protein Kinase Is Necessary For Binding and Phosphorylation of the Granulocyte-Macrophage Colony-stimulating Factor Receptor β Chain ∗

  Yanming Zhao;Fred Wagner;Stuart J. Frank;Andrew S. Kraft

  212
  Citations

• Pim family kinases enhance tumor growth of prostate cancer cells

  Wei Wei Chen;Daniel C. Chan;Carlton Donald;Michael B. Lilly

  211
  Citations